M.H. Fechter, A.E. Stu¨tz / Carbohydrate Research 319 (1999) 55–62
61
13
5-Azido-5-deoxy-
L
-tagatopyranose (25).—
ratio 2:1; C NMR (75.5 MHz, D2O): l 102.2
Application of the general isomerisation proce-
(C-1a), 97.6 (C-1b), 82.2 (C-4b), 82.0 (C-4a),
76.0, 72.3 (C-2a, C-3a), 72.1, 71.5 (C-2b, C-3b),
65.7 (C-6a), 64.7 (C-6b), 62.6, 62.1 (C-5a, C-
5b). Anal. Calcd for C6H11N3O5: C, 35.13; H,
5.40. Found: C, 35.01; H, 5.43.
dure to azidodeoxyaldose 21 (187 mg, 0.91
mmol) furnished ketose 25 (62.7 mg, 34%): H
1
NMR (300 MHz, D2O), major anomer: l
4.03–3.88 (m, 3 H, H-3, H-6, H-6%), 3.87-3.76
(m, 2 H, H-1, H-4), 3.68 (m, 1 H, H-5), 3.58 (d,
5-Azido-5-deoxy-
D-allofuranose
(22).—
13
1 H, J 11.8 Hz, H-1%), anomeric ratio 8:1; C
Compound 18 (790 mg, 1.62 mmol) was sub-
jected to the hydrolysis of protecting groups as
reported above to yield free azidodeoxyallose
22 (259 mg, 78%) as a colourless oil: 1H NMR
(300 MHz, D2O): l 5.42 (d, 1 H, J1,2 4.0 Hz, H-
1a), 5.27 (d, 1 H, J1,2 0.9 Hz, H-1b), a/b ratio
5:2; 13C NMR (75.5 MHz, D2O): l 102.0 (C-
1b), 97.2 (C-1a), 82.9 (C-4a), 81.7 (C-4b), 76.2,
71.8, 66.3 (C-2b, C-3b, C-6b), 71.8, 70.8, 65.5
(C-2a, C-3a, C-6a), 61.9 (C-5a, C-5b). Anal.
Calcd for C6H11N3O5: C, 35.13; H, 5.40.
Found: C, 35.09; H, 5.49.
NMR (75.5 MHz, D2O), major anomer: l 99.2,
(C-2) 70.9, 70.5 (C-3, C-4), 64.9 (C-6), 61.4 (C-
1), 59.2 (C-5). Anal. Calcd for C6H11N3O5: C,
35.13; H, 5.40. Found: C, 35.02; H, 5.47.
5-Azido-5-deoxy- -psicopyranose (26).—
D
Compound 22 (177 mg, 0.86 mmol) was iso-
merised according to the general procedure to
yield psicose derivative 26 (58.8 mg, 33%) as a
1
colourless syrup: H NMR (300 MHz, D2O),
anomeric ratio 1:1: l 4.35 (t, 1 H, J 2.6 Hz),
4.23 (t, 1 H, J 4.0 Hz), 4.13 (dd, 1 H, J 2.0, 12.9
Hz), 3.97 (m, 2 H), 3.85 (dd, 1 H, J 1.8, 12.9
Hz), 3.84–3.68 (m, 6 H), 3.57 (d, 1 H, J 11.9
5 - Deoxy -
D
- erythro - hex - 2 - ulopyranose
(23).—Following the general procedure, com-
pound 19 (150 mg, 0.91 mmol) was exposed to
immobilised glucose isomerase (Sweetzyme T,
500 mg) for 8 h to yield ketose 23 (55.1 mg,
37%): 1H NMR (300 MHz, D2O), major
anomer: d 4.14 (ddd, 1 H, J5%,6 3.0 Hz, J5,6 5.2
Hz, J6,6% 12.0 Hz, H-6), 3.94 (ddd, 1 H, J5%,6% 2.9
Hz, J5,6%B1 Hz, H-6%), 3.82–3.70 (m, 2 H, H-3,
H-4), 3.74 (d, 1 H, J1,1% 11.7 Hz, H-1), 3.51 (d, 1
H, H-1%), 1.88 (m, 1 H, H-5), 1.71 (m, 1 H, H-
5%), anomeric ratio 11:3; 13C NMR (75.5 MHz,
D2O): l 101.9, 99.1 (C-2a,b), 69.2, 69.0, 67.4,
66.4, 65.4, 64.3, 60.1,56.2 (C-1, C-3, C-4, C-
6a,b), 31.6, 28.1 (C-5a,b). Anal. Calcd for
C6H12O5: C, 43.90; H, 7.37. Found: C, 43.77;
H, 7.41.
13
Hz), 3.45 (d, 1 H, J 11.7 Hz); C NMR (75.5
MHz, D2O): l 99.2, 98.7 (C-2a,b), 71.2, 70.0,
66.6, 66.5, 64.9, 64.1, 62.0, 60.6(C-1, C-3, C-4,
C6a,b), 58.1, 57.0 (C-5a,b). Anal. Calcd for
C6H11N3O5: C, 35.13; H, 5.40. Found: C, 35.07;
H, 5.49.
2,5-Dideoxy-2,5-imino-
-altritol (28).—To a 1% methanolic solution
D-galactitol (27) and
-
L
of azidodeoxyketose 25 (62.7 mg, 0.31 mmol),
palladium-on-carbon (10%, 50 mg) was added
and the mixture was stirred at ambient tem-
perature under an atmosphere of hydrogen.
(Caution: MeOH–Pd/C mixtures are a fire
hazzard!) After 1 h, the catalyst was removed
by filtration and the filtrate was concentrated
under reduced pressure to give a 1:1 mixture of
known iminoalditol 27 and epimer 28 (45.9 mg,
5-Deoxy-5-fluoro- -tagatopyranose (24).—
L
Aldose 20 (167 mg, 0.92 mmol) was isomerised
to ketose 24 (58.8 mg, 35%) following the gen-
eral procedure: 1H NMR (300 MHz, D2O), ma-
jor anomer: l 4.76 (m, 1 H, J5,F 45.0 Hz, H-5),
4.14 (m, 1 H, H-6), 3.96 (m, 2 H, H-3, H-4),
3.83 (m, 1 H, H-6%), 3.74, 3.73 (2d, 1 H, H-1),
3.55, 3.50 (2d, 1 H, H-1%), anomeric ratio 3:2;
13C NMR (75.5 MHz, D2O): l 99.1, 99.0 (C-
2a,b), 90.9 (J5,F 174 Hz), 89.2 (J5,F 174 Hz) [C-
5a,b)], 71.4 (J3,F 8.9 Hz), 64.4 [C-3a,b], 70.4
(J4,F 17.4 Hz), 69.0 (J4,F 27.3 Hz) [C-4a,b], 64.6,
64.4 (C-1a,b), 60.4 (J6,F 29.9 Hz), 59.3 (J6,F 19.6
Hz) [C-6a,b]. Anal. Calcd for C6H11FO5: C,
39.56; H, 6.09. Found: C, 39.41; H, 6.02.
1
92%). Compound 27: H NMR (300 MHz,
D2O): l 4.40 (dd, 2 H, J3,4 1.6 Hz, J2,3 4.4 Hz,
H-3, H-4), 3.89 (dd, 2 H, J1,2 5.3 Hz, J1,1% 11.7
Hz, H-1, H-6), 4.13 (dd, 2 H, J1%,2 6.8 Hz, H-1%,
13
H-6%), 3.48 (m, 2 H, H-2,H-5); C NMR (75.5
MHz, D2O): l 72.1 (C-3, C-4), 61.2 (C-2, C-5),
1
60.5 (C-1, C-6); lit. [24]: H NMR (500 MHz,
CD3OD) l 3.55–3.65 (m, 2 H), 3.88 (dd, 2 H, J
8.0, 12.0 Hz), 3.92 (dd, 2 H, J 5.0, 12.0 Hz),
4.3–4.4 (m, 2 H); 13C NMR (125 MHz,
CD3OD): l 59.45, 63.08, 71.69. Compound 28:
13C NMR (75.5 MHz D2O): l 73.8, 72.4 (C-3,
C-4), 62.5, 61.8, 61.5, 60.6 (C-1, C-2, C-5, C-6);